Scientists say they may have found ‘complete cure’ for cancer

A small team of scientists in Israel say they are on the brink of releasing the first complete cure for cancer.

"We believe we will offer in a year's time a complete cure for cancer", said Dan Aridor from Accelerated Evolution Biotechnologies, the company the treatment is being developed for.

"We believe we will offer in a year's time a complete cure for cancer".

Morad equated the concept of MuTaTo to the drug cocktail that has helped transform AIDS from being an automatic death sentence to a chronic yet manageable disease, according to the Israeli news outlet.

Even hints at a cure for cancer are big news - according to statistics, every sixth death is a result of cancer, making it the second leading cause of death in the world after cardiovascular diseases.

The company, however, has only tested the treatment in mice so far and it can take six to seven years to bring cancer drugs from "mouse to market", even when drugmakers receive special permissions from USA regulators to speed drug development, Les Funtleyder, health-care portfolio manager at E Squared Capital Management, told CNBC.

American Cancer Society deputy chief medical officer J. Leonard Lichtenfeld he wrote on his blog: "We all have hope that a cure for cancer can be found and found quickly". But MuTato, as the Jerusalem Post notes, uses "a combination of several cancer-targeting peptides for each cancer cell at the same time, combined with a strong peptide toxin that would kill cancer cells specifically".

"If it does not completely annihilate the cancer, the remaining cells can start to get mutations again, and then the cancer comes back, but this time it is drug resistant", said Morad.

"Instead of attacking receptors one at a time, we attack receptors three at a time - not even cancer can mutate three receptors at the same time", Morad added.

Morad said MuTaTo is also strong enough to both destroy stem cells and penetrate where other drugs can not reach.

"Our solution will be both generic and personal", Aridor stated.

Aridor said that it's shown some success after mice testing.

AEBi is about to begin clinical trials that will wrap up in a few years. That means cancer patients can give a biopsy to the lab.



Other news